Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

56 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Low plasma PD-L1 levels, early tumor onset and absence of peritoneal carcinomatosis improve prognosis of women with advanced high-grade serous ovarian cancer.
Fanale D, Brando C, Corsini LR, Cutaia S, Di Donna MC, Randazzo U, Filorizzo C, Lisanti C, Magrin L, Gurrera V, Romano R, Dimino A, Bazan Russo TD, Olive D, Vieni S, Pantuso G, Giordano A, Chiantera V, Russo A, Bazan V, Iovanna JL. Fanale D, et al. Among authors: brando c. BMC Cancer. 2023 May 13;23(1):437. doi: 10.1186/s12885-023-10911-5. BMC Cancer. 2023. PMID: 37179293 Free PMC article.
Detection of Germline Mutations in a Cohort of 139 Patients with Bilateral Breast Cancer by Multi-Gene Panel Testing: Impact of Pathogenic Variants in Other Genes beyond BRCA1/2.
Fanale D, Incorvaia L, Filorizzo C, Bono M, Fiorino A, Calò V, Brando C, Corsini LR, Barraco N, Badalamenti G, Russo A, Bazan V. Fanale D, et al. Among authors: brando c. Cancers (Basel). 2020 Aug 25;12(9):2415. doi: 10.3390/cancers12092415. Cancers (Basel). 2020. PMID: 32854451 Free PMC article.
Baseline plasma levels of soluble PD-1, PD-L1, and BTN3A1 predict response to nivolumab treatment in patients with metastatic renal cell carcinoma: a step toward a biomarker for therapeutic decisions.
Incorvaia L, Fanale D, Badalamenti G, Porta C, Olive D, De Luca I, Brando C, Rizzo M, Messina C, Rediti M, Russo A, Bazan V, Iovanna JL. Incorvaia L, et al. Among authors: brando c. Oncoimmunology. 2020 Oct 27;9(1):1832348. doi: 10.1080/2162402X.2020.1832348. Oncoimmunology. 2020. PMID: 33178494 Free PMC article.
A "Lymphocyte MicroRNA Signature" as Predictive Biomarker of Immunotherapy Response and Plasma PD-1/PD-L1 Expression Levels in Patients with Metastatic Renal Cell Carcinoma: Pointing towards Epigenetic Reprogramming.
Incorvaia L, Fanale D, Badalamenti G, Brando C, Bono M, De Luca I, Algeri L, Bonasera A, Corsini LR, Scurria S, Iovanna JL, Russo A, Bazan V. Incorvaia L, et al. Among authors: brando c. Cancers (Basel). 2020 Nov 16;12(11):3396. doi: 10.3390/cancers12113396. Cancers (Basel). 2020. PMID: 33207823 Free PMC article.
BRCA1/2 pathogenic variants in triple-negative versus luminal-like breast cancers: genotype-phenotype correlation in a cohort of 531 patients.
Incorvaia L, Fanale D, Bono M, Calò V, Fiorino A, Brando C, Corsini LR, Cutaia S, Cancelliere D, Pivetti A, Filorizzo C, La Mantia M, Barraco N, Cusenza S, Badalamenti G, Russo A, Bazan V. Incorvaia L, et al. Among authors: brando c. Ther Adv Med Oncol. 2020 Dec 16;12:1758835920975326. doi: 10.1177/1758835920975326. eCollection 2020. Ther Adv Med Oncol. 2020. PMID: 33403015 Free PMC article.
Prognostic Role of Plasma PD-1, PD-L1, pan-BTN3As and BTN3A1 in Patients Affected by Metastatic Gastrointestinal Stromal Tumors: Can Immune Checkpoints Act as a Sentinel for Short-Term Survival?
Fanale D, Incorvaia L, Badalamenti G, De Luca I, Algeri L, Bonasera A, Corsini LR, Brando C, Russo A, Iovanna JL, Bazan V. Fanale D, et al. Among authors: brando c. Cancers (Basel). 2021 Apr 27;13(9):2118. doi: 10.3390/cancers13092118. Cancers (Basel). 2021. PMID: 33925671 Free PMC article.
Challenges and advances for the treatment of renal cancer patients with brain metastases: From immunological background to upcoming clinical evidence on immune-checkpoint inhibitors.
Incorvaia L, Madonia G, Corsini LR, Cucinella A, Brando C, Gagliardo C, Santoni M, Fanale D, Inno A, Fazio I, Foti G, Galia M, Badalamenti G, Bazan V, Russo A, Gori S. Incorvaia L, et al. Among authors: brando c. Crit Rev Oncol Hematol. 2021 Jul;163:103390. doi: 10.1016/j.critrevonc.2021.103390. Epub 2021 Jun 4. Crit Rev Oncol Hematol. 2021. PMID: 34090998 Review.
Prevalence and Spectrum of Germline BRCA1 and BRCA2 Variants of Uncertain Significance in Breast/Ovarian Cancer: Mysterious Signals From the Genome.
Fanale D, Fiorino A, Incorvaia L, Dimino A, Filorizzo C, Bono M, Cancelliere D, Calò V, Brando C, Corsini LR, Sciacchitano R, Magrin L, Pivetti A, Pedone E, Madonia G, Cucinella A, Badalamenti G, Russo A, Bazan V. Fanale D, et al. Among authors: brando c. Front Oncol. 2021 Jun 11;11:682445. doi: 10.3389/fonc.2021.682445. eCollection 2021. Front Oncol. 2021. PMID: 34178674 Free PMC article.
56 results